Fintech PR
CGTN: How does China transfer its market to a shared one for the world?
BEIJING, Nov. 8, 2023 /PRNewswire/ — American entrepreneur Owen Messick happily recalls his company’s “surprising” experience at the first China International Import Expo (CIIE). “I remember that first CIIE very well. It was quite a big impact to us as a company, to me personally.”
According to Messick, his company, doTERRA, booked a 9-square-meter booth to test the waters at the inaugural edition of the CIIE in 2018. However, that tiny booth brought the American essential oil brand tentative deals worth 380 million yuan ($55.48 million).
“Heartened by the expo’s spillover effect, we set up a regional headquarters in Shanghai only a month after the first CIIE and began to build a factory and our first overseas laboratory in China,” said Messick, who is now the president of doTERRA China.
The company has expanded its booth to 200 square meters at the sixth CIIE, which takes place from November 5 to 10 this year in Shanghai.
Looking back to the first CIIE, Messick says he was struck by the speech delivered by Chinese President Xi Jinping at the opening ceremony.
“I think the main message that he gave was, look, China is open to the world, we are open to having businesses come to China and be successful here. So I think that has really encouraged many companies, including us.”
In a letter to the sixth CIIE, the Chinese president reaffirmed China’s commitment to high-level opening up, pledging that China will firmly advance high-standard opening up and continue to make economic globalization more open, inclusive, balanced and beneficial.
Chinese market, a market for all
China has a population of over 1.4 billion people and a middle-income group of over 400 million people, presenting huge potential in terms of market demand, Chinese Premier Li Qiang said on Sunday in his keynote speech at the opening ceremony of the sixth CIIE.
According to Li, China’s imports of goods and services are expected to reach $17 trillion in cumulative terms in the next five years.
Any country, no matter its size and strength, can utilize CIIE as an opportunity to access China’s large market. Guinea-Bissau, which is located on the west coast of Africa, is a good example.
The country is one of the world’s largest producers of cashew nuts. More than 80 percent of its workforce is in the cashew nut industry, and cashew nuts constitute more than 90 percent of its total exports. Cashew nuts are thus not only a crucial income source for the locals but also a key driver of the country’s economy.
At the fifth CIIE last year, a free 18-square-meter booth was offered to Guinea-Bissauan companies to showcase their products, enabling them to tap into the Chinese market.
During last year’s expo, many enterprises expressed a strong interest in Guinea-Bissau’s cashew nut industry and some even set out plans to invest in the African country, said Antonio Serifo Embalo, ambassador of the Republic of Guinea-Bissau to China.
The sixth CIIE again offers complimentary exhibition booths to exhibitors from the least developed countries, like Guinea-Bissau, to help more products from such nations enter the Chinese market.
The CIIE’s approach echoes Xi’s words. In his letter, the Chinese president said he hopes the CIIE will better serve as a window for fostering a new development pattern that creates new opportunities for the world through China’s further development, and as a platform of high-standard opening up that allows China’s enormous market to be shared by the world.
Win-win cooperation for world
Noting that the world economic recovery lacks momentum and requires the solidarity and cooperation of all countries, Xi in the letter expressed hope that the CIIE will play a greater role in providing shared international public goods and services that facilitate an open world economy and let the world benefit from win-win cooperation.
Speaking at last month’s third Belt and Road Forum for International Cooperation, the Chinese president highlighted that win-win cooperation is the sure route to success.
The CIIE has become an important platform for exhibitors from Belt and Road Initiative (BRI) partner countries to enter the Chinese market and achieve win-win outcomes.
Over 1,500 enterprises from Belt and Road partner countries are attending the sixth CIIE, with their exhibition area totaling nearly 80,000 square meters, an increase of 30 percent from last year’s event.
“We are witnessing signs of a slowdown in the globalization process, with geopolitical tensions, trade barriers and other factors causing many countries to focus more on domestic consumption,” Kevin Kolevar, vice-president of global policy and government affairs at Dow, commented. “However, China has always been signaling openness. As a country with the world’s largest consumer base, China holds tremendous potential.”
He noted that the CIIE symbolizes China’s commitment to and support for economic globalization and international cooperation and openness, adding that the expo not only serves as a platform for global business cooperation but also facilitates communication and interaction among leaders from different regions.
Photo – https://mma.prnewswire.com/media/2270636/1.jpg
View original content:https://www.prnewswire.co.uk/news-releases/cgtn-how-does-china-transfer-its-market-to-a-shared-one-for-the-world-301981479.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News7 days ago
AI-powered Panax raises $15m to reshape cash flow management
-
Latest News7 days ago
Egypt’s Swypex launches an all-in-one fintech platform after $4m seed round
-
Latest News7 days ago
Sweden’s Mitigram names Pedram Tadayon as new CEO
-
Latest News6 days ago
Sobha Developers bring to Singapore an Exclusive Dubai Property Showcase
-
Latest News7 days ago
South African fintech Lesaka snaps up Adumo in $86m deal
-
Latest News5 days ago
Al Hassan Ghazi Ibrahim Shaker Co. announces a strong start to FY24, reporting a 12.09% YoY increase in net profit to reach SAR 32.25 million in Q1-FY24
-
Latest News5 days ago
Major Korean pension fund invests in carbon solutions with Stafford Capital Partners
-
Latest News4 days ago
Newgen Recognized in the Gartner® Market Guide for Commercial Banking Cash Management and Trade Finance Solutions 2023 Report